Product Information

CEQUA 0.09% SOLUTION is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $10.3814 per EA under NDC 47335050696. Its NADAC has been published 336 times since Mar 18, 2020.

FDA first approved this application on Aug 14, 2018.

The High Outlier badge above means this manufacturer's average price in the cyclosporine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CEQUA 0.09% SOLUTION

cyclosporine

$10.3814per EA

High Outlier

Strength

.0009 g/mL

Manufacturer

Sun Pharmaceutical Industries Inc.

NDC

47335050696

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC; TOPICAL

Effective Date

8/19/2026

Active Ingredients

CYCLOSPORINE

Approval Type

New Drug (NDA)

FDA Application

NDA210913

FDA Approved

8/14/2018

On Market Since

8/15/2018

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant

Calcineurin Inhibitors

Cytochrome P450 3A4 Inhibitors

P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CEQUA 0.09% SOLUTION has been published 336 times since Mar 18, 2020, and over the history we have for it it has risen 27.7%. The table below summarizes its recorded NADAC range and movement.

Current price	$10.3814 per EA
All-time high	$10.3843 (Jul 15, 2026)
All-time low	$8.1097 (Dec 23, 2020)
52-week high	$10.3843
52-week low	$10.0532
Median price	$8.9448
Average price	$9.1071
Largest weekly change	+7.5% (Jan 15, 2025)
Weeks tracked	336
Tracking since	Mar 18, 2020

Price History

-0.0%

+3.2%

+16.1%

+23.1%

All

+27.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cyclosporine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TIAZAC ER 180 MG CAPSULE

Brand

00187261330•Bausch Health US LLC

$1.5060

per EA

TIAZAC ER 180 MG CAPSULE

Brand

00187261390•Bausch Health US LLC

$1.5060

per EA

MYRBETRIQ ER 8 MG/ML SUSP

Brand

00469502099•Astellas Pharma US, Inc.

$2.2069

per ML

ZONISADE 100 MG/5 ML ORAL SUSP

Brand

52652800101•Azurity Pharmaceuticals Inc.

$2.7505

per ML

TIAZAC ER 360 MG CAPSULE

Brand

00187261630•Bausch Health US LLC

$2.7628

per EA

TIAZAC ER 360 MG CAPSULE

Brand

00187261690•Bausch Health US LLC

$2.7628

per EA

ASTAGRAF XL 0.5 MG CAPSULE

Brand

00469064773•Astellas Pharma US, Inc.

$2.7786

per EA

KALETRA 80 MG-20 MG/ML SOLN

Brand

00074395646•AbbVie Inc.

$3.1186

per ML

CARDIZEM LA 120 MG TABLET

Brand

00187204530•Bausch Health US LLC

$3.6467

per EA

CARDIZEM LA 120 MG TABLET

Brand

00187204590•Bausch Health US LLC

$3.6467

per EA

Frequently asked questions

What is the NADAC price of CEQUA 0.09% SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for CEQUA 0.09% SOLUTION, manufactured by Sun Pharmaceutical Industries Inc., is $10.3814 per EA (NDC 47335050696), effective Aug 19, 2026.

How has the price of CEQUA 0.09% SOLUTION changed over time?

Over the history we have for it, the NADAC for CEQUA 0.09% SOLUTION has risen 27.7%. It has been tracked across 336 weekly CMS publications since Mar 18, 2020.

What are the highest and lowest recorded NADAC prices for CEQUA 0.09% SOLUTION?

Since Mar 18, 2020, the NADAC for CEQUA 0.09% SOLUTION has ranged from a low of $8.1097 (Dec 23, 2020) to a high of $10.3843 (Jul 15, 2026), with a median of $8.9448 per EA.

Are there cheaper alternatives to CEQUA 0.09% SOLUTION?

No other NADAC-published product currently shares the active ingredient and strength of CEQUA 0.09% SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CEQUA 0.09% SOLUTION?

CEQUA 0.09% SOLUTION (NDC 47335050696) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.